Harnessing the power of AI to align
stakeholders towards outcomes
.png)
.png){kind=small}
Healthcare provider preferences are shifting... physicians expect engagement to be patient-centric, compliant, and purposeful. Outdated engagement methods and fragmented systems have led to a disconnect between pharma, physicians, and patients.
.png)
At iksa, we believe the healthcare ecosystem starts with the physician-patient relationship. Our AI model is specifically trained to bridge the gap between pharma, physicians, and patients by aligning incentives towards patient outcomes.
.png)
Patient engagement is more than just communication... it's about understanding with empathy and personalizing care through the treatment journey. Patients need us to meet them where they are, yet many still continue to fall through the cracks... this is the health gap.
.png)
The iksa.ai engine supercharges your patient initiatives with the level of customization and personalization you need to improve patient loyalty, increase adherence, and drive patient outcomes — all while maintaining the highest standards of regulatory compliance.
Despite improvements in visibility at the point of care, correlating clinical and financial ROI remains unclear. We know how difficult this makes it to tailor commercial strategies based on a data-driven understanding of therapeutic journeys, especially across different segments.
.png)
iksa.ai equips your team with real-time insights through custom analytics dashboards, allowing you to correlate trends in outcomes and behaviors to optimize your strategies for high-value segments.
Harness the power of AI to align stakeholders towards outcomes
Healthcare provider preferences are shifting... physicians expect engagement to be patient-centric, compliant, and purposeful. Outdated engagement methods and fragmented systems have led to a disconnect between pharma, physicians, and patients.
.png){kind=small}
At iksa, we believe the foundation of the healthcare ecosystem is the physician-patient relationship. Our AI model is specifically trained to bridge the gap between pharma, physicians, and patients by aligning incentives towards patient outcomes.
Patient engagement is more than just communication... it's about understanding with empathy and personalizing care through the treatment journey. Patients need us to meet them where they are, yet many still continue to fall through the cracks... this is the health gap.
The iksa.ai engine supercharges your patient initiatives with the level of customization and personalization you need to improve the post prescription journey — driving adherence and patient outcomes — all while maintaining the highest standards of regulatory compliance.
Despite improvements in visibility at the point of care, correlating clinical and financial ROI remains unclear. We know how difficult this makes it to tailor commercial strategies based on a data-driven understanding of therapeutic journeys, especially across different segments.
iksa.ai streamlines the therapeutic journey while equipping your teams and partners with real-time insights. Our dashboards can be customized for the trends and outcomes you need to correlate for optimal clinical and commercial strategy.
Enable your physicians to drive a tailored continuum of care for your therapeutics
Not all patients are the same, and our AI understands this deeply — at the core of iksa.ai is an Adaptive AI model trained on over 60 million patient interactions with 100,000 parameters for patient journey personalization — constantly refining and learning from every interaction. Ensure patients get the post prescription support they need with tailored education, behavioral nudges, monitoring, reminders, and issue resolution. Our data flywheel powers predictive outcomes, using a feedback loop of self-teaching neural networks to enhance engagement and outcomes with every cycle.
.svg)
As healthcare professionals ourselves, we understand the promise of AI, but also the risks of generative models. When we set out to build our model, our first principles were maintaining the highest levels of ethics, safety, caution, and compliance. The model eliminates the risk of AI "hallucinations" by combining open input with closed, clinically validated outputs from a decade of clinical trials with 65K+ patients.
.png)
.png)
It’s refreshing to have a tool that improves both patient outcomes and our relationship with doctors. Physicians embrace it because it enhances patient care, without disrupting their clinical practice, and providing clear and tangible clinical benefits.
— Head of Marketing, Indian Pharma
The iksa team has supported us from strategy to implementation, co-creating the program with our teams and ensuring the right metrics were being tracked. The single source of truth for behavior modification and outcomes is a real gamechanger.
— BU Head, Global Pharma
Working with iksa.ai allows us to focus on omnichannel strategy while automating clinical content customization and personalization. I like that it is plug and play across channels, and the dashboard gives better visibility than we have had before.
— VP of Marketing, Indian Pharma
With the complexity of managing AI in healthcare, Gen AI wasn’t going to cut it. We needed a solution with built-in safeguards approach ensures everything stays compliant, and the outcomes we’re seeing are aligned with our goals.
— Medical Affairs Lead, Global Pharma
Engaging physicians and patients is a delicate balance that Iksa does well. We were satisfied with data security standards and strict protocol definition, especially when it comes to clinical domains.
— Compliance Director, Global Pharma
The iksa team is your end-to-end partner for patient and physician engagement. Reach out to explore how our platform can support your growth targets while improving patient outcomes.
.png)
.png)
